Skip to main content
. 2010 Jul 1;469(1):225–236. doi: 10.1007/s11999-010-1453-y

Table 5.

Survivorship and clinical results in published series

Study Prosthesis Series Lost at followup Mean followup Survival rate (followup) Revisions Function
TAA/patients (years) (%) Followup (years) 95% CI (%) End point Fusion Exchange Reoperation Score Results
Wood et al. [52] STAR 200/187 0 7.3 80.3 10 71–89.6 Fusion or revision (including PE) 20 4 6 AOFAS Pain: 35 (0–40) Function: 40 (20–54)
Knecht et al. [26] Agility 132/126 12 9 63 11 35–90 Fusion or revision (PE excluded) 7 7 32 AOS [12] 2.55 ± 2.31
Buechel et al. [9] Buechel-Pappas (shallow sulcus) 40/38 0 12 74.2 20 35–100 Revision * * * NJOH [8] 28: good/excellent Two: fair 10: poor
Buechel et al. [9] Buechel-Pappas (deep sulcus) 75/74 0 5 92 12 55–100 Revision * * * NJOH [8] 66 good/excellent Four: fair Five: poor
San Giovanni et al. [40] Buechel-Pappas 31/23 0 8.3 93.4 12 83–100 Fusion 2 AOFAS 81 (40–92)
Kofoed [28] STAR (cemented) 33/33 0 9.4 70 12 60.3–78.5 Fusion or revision 4 5 0 Kofoed [28] 74.2 ± 19.3
Kofoed [28] STAR 25/25 0 9.4 95.4 12 91–99.9 Fusion or revision 0 2 0 Kofoed [28] 91.7 ± 7.4
Karantana et al. [24] STAR 52/45 0 5 to 9 65 9 24.3–88 Fusion or revision 2 6 9 AOFAS 78 ± 18 (range, 30–100)
Doets et al. [11] LCS and Buechel-Pappas 93/76 0 7.6 84 16.3 73–93 Fusion or revision 13 2 * AOFAS 77 ± 3.8
Current series Salto (mobile-bearing) 98/96 0 8.9 84.8 11 75–95 Fusion or revision (including PE) 6 5 13 AOFAS 79.3 ± 11.9

Selected on the basis of a mean followup more than 5 years * not mentioned in the article; deceased patients excluded; TAA = total ankle arthroplasty; CI = confidence interval; PE = polyethylene; AOFAS = American Orthopaedic Foot and Ankle Society; AOS = ankle osteoarthritis scale; NJOH = New Jersey Orthopaedic Hospital ankle scoring scale.